Cold-cough

Commercial

Portfolio-7447-for-WEB

NCE Pipeline

Discovery-7447-for-WEB

Research

Latest Report and Accounts

Vernalis plc - AR 30-06-2016 - FINAL - COVER PAGE WEBSITE

30 June, 2016

2015/16 Results Download our latest report...

Archive

Latest Presentation

ceo21 February, 2017

Our latest presentation is available to view from here...


Archive

Share Price

Share price:  17.50p
Change:  -0.77 (-4.37%)
As at:  29 June 2017 11:48:43
Volume:  21,795
LSE ID:  VER

Share price details

Latest News

Servier and Vernalis plc announce achievement of 3 milestones in their oncology drug discovery collaboration

Servier and Vernalis plc are pleased to announce the achievement of two research milestones and one clinical milestone in their oncology drug discovery collaboration, triggering a total payment of €2 million to Vernalis.

 

Read more ...

At a glance

More information on Vernalis and its pipeline ...

FactsheetNov14 Company fact sheet

Comm thumbnail Explore the pipeline ...

Contact Vernalis

T: 0118 938 0000
F: 0118 938 0001

Contact information
Maps and directions
Contact form

To report SUSPECTED ADVERSE REACTIONS, contact Vernalis Therapeutics, Inc. at 1-855-705-9546 and drugsafety@propharmagroup.com or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch